Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name file name title title
tabling member	label

Search

1125504

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the recommendations by the Joint Committee on Vaccination and Immunisation to reduce the infant pneumococcal vaccination schedule from three doses to two.
tabling member printed	Baroness Masham of Ilton
uin	HL15599
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15600 question first answered 22/05/2019 14:50:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf title JCVI Minute 2015
tabling member	1850 label Biography information for Baroness Masham of Ilton

1125505

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pneumococcal Diseases: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what analyses they have conducted of the risks and benefits of reducing the infant pneumococcal vaccination schedule from 2+1 to 1+1; and whether they will publish the results any such analyses.
tabling member printed	Baroness Masham of Ilton
uin	HL15600
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15599 question first answered 22/05/2019 14:50:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf title JCVI Minute 2015
tabling member	1850 label Biography information for Baroness Masham of Ilton

1125506

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV.
tabling member printed	Baroness Masham of Ilton
uin	HL15601
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Public Health England, in partnership with NHS England and the Department, is taking steps to improve vaccination coverage in England, including for people living with HIV.</p><p>These steps include initiatives to improve access to the immunisation programme; communication with the public; data to identify underserved individuals and populations; and training for healthcare professionals, changes to vaccination eligibility criteria; launching disease elimination strategies; running targeted social media campaigns; providing information leaflets in multiple languages and running e-learning programme for healthcare practitioners.</p><p>Certain vaccines are delivered through sexual health services that particularly benefit people living with HIV. This includes vaccines for hepatitis A, hepatitis B and human papillomavirus. People living with HIV are in the influenza risk groups and are invited for the flu vaccine on an annual basis.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:50:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1122911

registered interest
date	24/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether private hospitals in England are required to provide safety records to the Care Quality Commission to protect patients as provided by the NHS.
tabling member printed	Baroness Masham of Ilton
uin	HL15302
answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>Private hospital providers are required by law to notify the Care Quality Commission (CQC) about the following occurrences:</p><p>- A serious injury to a person using the service;</p><p>- The death of a person using the service;</p><p>- An incident relating to the service that is reported to or investigated by the police;</p><p>- Something that stops or may stop the service running safely (such as problems with infrastructure, equipment or premises);</p><p>- Safeguarding issue such as abuse or allegations of abuse concerning a person using the service if any of the following applies:</p><ol><li>the person is affected by abuse or alleged abuse</li><li>the person is an abuser or an alleged abuser; and</li></ol><p>- Any application and its outcome or withdrawal to deprive a person of their liberty.</p> answering member printed Baroness Blackwood of North Oxford question first answered 07/05/2019 14:53:35 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1092448

registered interest
date	20/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hyperkalaemia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to promote awareness of hyperkalaemia and its implications for patients with chronic kidney disease and heart failure.
tabling member printed	Baroness Masham of Ilton
uin	HL14703
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>On 8 August 2018, NHS Improvement issued a National Patient Safety Alert to support safe and timely management of hyperkalaemia through a range of resources that would help organisations ensure their clinical staff have easily accessible information to guide prompt investigation, treatment and monitoring options. The resources include clinical practice guidelines from the UK Renal Association on treatment of acute hyperkalaemia in adults and an awareness video from NHS Improvement for hospital staff. A copy of <em>Patient Safety Alert:</em> <em>Resources to support safe and timely management of hyperkalaemia</em> (<em>high level of potassium in the blood</em>) is attached.</p><p>National Patient Safety Alerts are issued through the Central Alerting System (CAS); a web-based cascading system for issuing patient safety alerts, important public health messages and other safety critical information and guidance to the National Health Service and others, including independent providers of health and social care.</p><p>NHS trusts are required to respond via CAS stating whether they are compliant with the actions and the timescale provided in all patient safety alerts or whether the alert is not relevant to them.</p><p>NHS Improvement has been working closely with the Care Quality Commission (CQC) to ensure that inspection teams are aware of national patient safety alerts that have been recently issued and that they review the actions taken in response to national patient safety alerts during their inspections.</p><p>In addition, the Department commissioned the CQC to work with NHS Improvement to understand the issues in NHS trusts that contribute to ‘Never Events’; part of this work looked at how effectively trusts use safety guidance and how other system partners support the implementation of safety guidance. A report, <em>Opening the door to change: NHS safety culture</em> <em>and the need for transformation </em>was published at the end of last year and a copy is attached.</p><p><strong> </strong></p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name Patient_Safety_Alert_-_Resources_to_support_safe_management_of_hyperkalaemia.pdf title Patient Safety Alert 2 file name 20181224_openingthedoor_report.pdf title Opening the door to change grouped question UIN HL14704 HL14705 question first answered 02/04/2019 13:56:47 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1092449

registered interest
date	20/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hyperkalaemia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what guidance and support they have provided on the implementation of the NHS Improvement's Patient Safety Alert on hyperkalaemia.
tabling member printed	Baroness Masham of Ilton
uin	HL14704
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>On 8 August 2018, NHS Improvement issued a National Patient Safety Alert to support safe and timely management of hyperkalaemia through a range of resources that would help organisations ensure their clinical staff have easily accessible information to guide prompt investigation, treatment and monitoring options. The resources include clinical practice guidelines from the UK Renal Association on treatment of acute hyperkalaemia in adults and an awareness video from NHS Improvement for hospital staff. A copy of <em>Patient Safety Alert:</em> <em>Resources to support safe and timely management of hyperkalaemia</em> (<em>high level of potassium in the blood</em>) is attached.</p><p>National Patient Safety Alerts are issued through the Central Alerting System (CAS); a web-based cascading system for issuing patient safety alerts, important public health messages and other safety critical information and guidance to the National Health Service and others, including independent providers of health and social care.</p><p>NHS trusts are required to respond via CAS stating whether they are compliant with the actions and the timescale provided in all patient safety alerts or whether the alert is not relevant to them.</p><p>NHS Improvement has been working closely with the Care Quality Commission (CQC) to ensure that inspection teams are aware of national patient safety alerts that have been recently issued and that they review the actions taken in response to national patient safety alerts during their inspections.</p><p>In addition, the Department commissioned the CQC to work with NHS Improvement to understand the issues in NHS trusts that contribute to ‘Never Events’; part of this work looked at how effectively trusts use safety guidance and how other system partners support the implementation of safety guidance. A report, <em>Opening the door to change: NHS safety culture</em> <em>and the need for transformation </em>was published at the end of last year and a copy is attached.</p><p><strong> </strong></p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name Patient_Safety_Alert_-_Resources_to_support_safe_management_of_hyperkalaemia.pdf title Patient Safety Alert 2 file name 20181224_openingthedoor_report.pdf title Opening the door to change grouped question UIN HL14703 HL14705 question first answered 02/04/2019 13:56:47 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1092450

registered interest
date	20/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hyperkalaemia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to address the patient safety concerns expressed in NHS Improvement's Patient Safety Alert on hyperkalaemia.
tabling member printed	Baroness Masham of Ilton
uin	HL14705
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>On 8 August 2018, NHS Improvement issued a National Patient Safety Alert to support safe and timely management of hyperkalaemia through a range of resources that would help organisations ensure their clinical staff have easily accessible information to guide prompt investigation, treatment and monitoring options. The resources include clinical practice guidelines from the UK Renal Association on treatment of acute hyperkalaemia in adults and an awareness video from NHS Improvement for hospital staff. A copy of <em>Patient Safety Alert:</em> <em>Resources to support safe and timely management of hyperkalaemia</em> (<em>high level of potassium in the blood</em>) is attached.</p><p>National Patient Safety Alerts are issued through the Central Alerting System (CAS); a web-based cascading system for issuing patient safety alerts, important public health messages and other safety critical information and guidance to the National Health Service and others, including independent providers of health and social care.</p><p>NHS trusts are required to respond via CAS stating whether they are compliant with the actions and the timescale provided in all patient safety alerts or whether the alert is not relevant to them.</p><p>NHS Improvement has been working closely with the Care Quality Commission (CQC) to ensure that inspection teams are aware of national patient safety alerts that have been recently issued and that they review the actions taken in response to national patient safety alerts during their inspections.</p><p>In addition, the Department commissioned the CQC to work with NHS Improvement to understand the issues in NHS trusts that contribute to ‘Never Events’; part of this work looked at how effectively trusts use safety guidance and how other system partners support the implementation of safety guidance. A report, <em>Opening the door to change: NHS safety culture</em> <em>and the need for transformation </em>was published at the end of last year and a copy is attached.</p><p><strong> </strong></p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name Patient_Safety_Alert_-_Resources_to_support_safe_management_of_hyperkalaemia.pdf title Patient Safety Alert 2 file name 20181224_openingthedoor_report.pdf title Opening the door to change grouped question UIN HL14703 HL14704 question first answered 02/04/2019 13:56:47 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1086373

registered interest
date	11/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology: Recruitment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to improve the recruitment of dermatologists in England.
tabling member printed	Baroness Masham of Ilton
uin	HL14405
answer	answer is ministerial correction date of answer 25/03/2019 answer text <p>The number of medical specialty training places that are available each year is set by Health Education England (HEE) and based on their assessment of service gaps and predicted workforce needs.</p><p>Dermatology is a highly competitive specialty training pathway and often oversubscribed. Nationally and locally there has been a 100% fill rate in dermatology training for the past four years.</p><p>It is the responsibility of individual National Health Service trusts to have staffing arrangements in place that deliver safe and effective care. This includes recruiting the staff needed to support these levels and meet local needs.</p><p>There has been a 22% increase in full time equivalent (FTE) dermatologists (doctors at the consultant grade) in post since September 2010, with 1,049 FTE dermatologists working in the NHS in November 2018. Harrogate and District NHS Foundation Trust is fully recruited for dermatology consultants. In addition, the Trust is currently recruiting for an extra dermatologist post to add extra treatment capacity.</p><p>In December 2018, performance for dermatology referral-to treatment waiting times at Harrogate and District NHS Foundation Trust, for patients on an incomplete pathway, was 97.9%. This is 10.1 percentage points higher than the national performance for dermatology, which was 87.8%.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL14406 question first answered 25/03/2019 14:21:19 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1086375

registered interest
date	11/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Harrogate and District NHS Foundation Trust: Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made, if any, of (1) the availability of consultant dermatologists, and (2) waiting times for dermatology outpatient services in Harrogate and District NHS Foundation Trust.
tabling member printed	Baroness Masham of Ilton
uin	HL14406
answer	answer is ministerial correction date of answer 25/03/2019 answer text <p>The number of medical specialty training places that are available each year is set by Health Education England (HEE) and based on their assessment of service gaps and predicted workforce needs.</p><p>Dermatology is a highly competitive specialty training pathway and often oversubscribed. Nationally and locally there has been a 100% fill rate in dermatology training for the past four years.</p><p>It is the responsibility of individual National Health Service trusts to have staffing arrangements in place that deliver safe and effective care. This includes recruiting the staff needed to support these levels and meet local needs.</p><p>There has been a 22% increase in full time equivalent (FTE) dermatologists (doctors at the consultant grade) in post since September 2010, with 1,049 FTE dermatologists working in the NHS in November 2018. Harrogate and District NHS Foundation Trust is fully recruited for dermatology consultants. In addition, the Trust is currently recruiting for an extra dermatologist post to add extra treatment capacity.</p><p>In December 2018, performance for dermatology referral-to treatment waiting times at Harrogate and District NHS Foundation Trust, for patients on an incomplete pathway, was 97.9%. This is 10.1 percentage points higher than the national performance for dermatology, which was 87.8%.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL14405 question first answered 25/03/2019 14:21:19 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1086376

registered interest
date	11/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many patients with (1) suspected skin cancer, (2) psoriasis, and (3) atopic dermatitis were (a) referred by a GP, and (b) seen by a consultant dermatologist in England during the last 12 months.
tabling member printed	Baroness Masham of Ilton
uin	HL14407
answer	answer is ministerial correction date of answer 25/03/2019 answer text <p>This information is not available in the format requested.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/03/2019 14:21:29 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton